title: [The use of peripherally inserted central catheter (PICC) in patients with hematological malignancies--a single center experience].
abstract: AIM. In this study we presented our experience with peripherally inserted central venous catheter (PICC) in patients with hematological malignancies.
  
  
  METHODS
  In the period from 2009 to 2012, a total of 105 PICCs were inserted in 90 patients. Patients with Non-Hodgkin lymphoma treated with DA-EPOCH comprised almost 40% of the cohort.
  
  
  RESULTS
  The total PICC in-dwell time was 14781 days with a median of 129 days (range 8-570 days). Malposition of the PICC occurred in 12 patients (11.4%) with a successful reposition or re-insertion. In 39 patients (37%) PICC was removed before the end of treatment due to suspected or proven infection (30 patients, 29%; 2.03 per 1000 PICC days), thrombosis associated with PICC in four patients (3.8%), occlusion of the PICC (two patients), misplaced catheter (two patients), and suspected thromboembolism in a single patient.
  
  
  CONCLUSIONS
  PICC is a safe and convenient long-term venous access in patients with hematological malignancies.
authors.forename: Zdravko
authors.initials: Z
authors.lastname: Mitrović
authors.forename: Igor
authors.initials: I
authors.lastname: Komljenović
authors.forename: Ozren
authors.initials: O
authors.lastname: Jaksic
authors.forename: Zeljko
authors.initials: Z
authors.lastname: Prka
authors.forename: Sandra Sestan
authors.initials: SS
authors.lastname: Crnek
authors.forename: Radmila Ajduković
authors.initials: RA
authors.lastname: Stojsavljević
authors.forename: Mario
authors.initials: M
authors.lastname: Pirsic
authors.forename: Visnja
authors.initials: V
authors.lastname: Haris
authors.forename: Rajko
authors.initials: R
authors.lastname: Kusec
authors.forename: Diana
authors.initials: D
authors.lastname: Dautovic
authors.forename: Vlatko
authors.initials: V
authors.lastname: Pejsa
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002405:Catheterization, Central Venous / Q000379:methods*; D002408:Catheters, Indwelling; D016638:Critical Illness / Q000628:therapy; D017523:Croatia; D005260:Female; D019337:Hematologic Neoplasms / Q000188:drug therapy*; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy; D008297:Male; D008875:Middle Aged; D013923:Thromboembolism / Q000628:therapy; D016896:Treatment Outcome